Visfatin regulates genes related to lipid metabolism in porcine adipocytes.
Visfatin is a visceral adipose tissue-specific adipocytokine that plays a positive role in attenuating insulin resistance by binding to the insulin receptor. Visfatin has been suggested to play a role in the regulation of lipid metabolism and inflammation; however, the mechanism remains unclear. We investigated the effects of visfatin on the regulation of gene expression in cultured porcine preadipocytes and differentiated adipocytes. In preadipocytes, the mRNA abundance of lipoprotein lipase and PPARgamma were significantly increased by visfatin or insulin treatment after 8 d (all P < 0.05). In the presence of insulin, the mRNA abundance of adipocyte fatty acid-binding protein was 24.7-fold greater than in the untreated group (P < 0.05), whereas visfatin alone had no effect on adipocyte fatty acid-binding protein mRNA abundance. Adipocyte differentiation was induced by insulin treatment for 8 d. In differentiated porcine adipocytes, exposure to insulin or visfatin for 24 h increased (P < 0.05) fatty acid synthase mRNA abundance but had no effect on the expression of sterol regulatory element binding-protein 1c mRNA. We also found a 5.8-fold upregulation of IL-6 expression in porcine adipocytes after 24 h of treatment with visfatin (P < 0.05). These results demonstrated that visfatin upregulated lipoprotein lipase expression in preadipocytes, potentially facilitating lipid uptake, and increased the gene expression of fatty acid synthase in differentiated adipocytes to potentially enhance lipogenic activity. Furthermore, visfatin can upregulate IL-6 expression in differentiated porcine adipocytes. The information presented in this study provides insights into the roles of visfatin in lipid metabolism in pigs.
Yang
C C
CC
Department of Animal Science and Technology, National Taiwan University, Taipei, Taiwan, ROC.
Deng
S J
SJ
Hsu
C C
CC
Liu
B H
BH
Lin
E C
EC
Cheng
W T K
WT
Wang
P H
PH
Ding
S T
ST
D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D002478:Cells, Cultured; D015971:Gene Expression Regulation, Enzymologic / Q000235:genetics*; D007328:Insulin / Q000378:metabolism; D050356:Lipid Metabolism / Q000187:drug effects* / Q000235:genetics; D008071:Lipoprotein Lipase / Q000096:biosynthesis / Q000235:genetics; D054409:Nicotinamide Phosphoribosyltransferase / Q000502:physiology*; D047495:PPAR gamma / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000662:veterinary; D051780:Sterol Regulatory Element Binding Protein 1 / Q000096:biosynthesis / Q000378:metabolism; D013552:Swine / Q000235:genetics*
D007328:Insulin; D047495:PPAR gamma; D012333:RNA, Messenger; D011994:Recombinant Proteins; D051780:Sterol Regulatory Element Binding Protein 1; D054409:Nicotinamide Phosphoribosyltransferase; D008071:Lipoprotein Lipase